Observational study on Hepatitis D patients in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a comprehensive overview of Hepatitis Delta virus (HDV) patients in metropolitan France over one year. It will assess the number of HDV tests conducted and compare these figures to the expected number based on Hepatitis B virus (HBV) screenings. The study will utilize data from French Health insurance and private and hospital laboratories to identify barriers to screening and care for HDV patients. The ultimate goal is to propose solutions to improve screening and treatment access for these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* \>18 years at the second step
* HDV RNA positive patients identified at the second step
* Patients non opposed to the collection of their data

Exclusion Criteria:

* Opposition expressed by the patients for the collection of their data

Where it's running

• Chu Limoges
  Limoges, France Recruiting

Study contacts

• Principal investigator: Véronique Loustaud-Ratti, Pr — University Hospital, Limoges
• Study coordinator: Sandra Juge
• Email: Sandra.Juge@chu-limoges.fr
• Phone: 0555056414

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oral and gum health and saliva markers in people with hepatitis B and D

  This project will test whether gum inflammation and specific saliva and gum-fluid markers differ in adults with hepatitis B and D—both those taking bulevirtide and those not—compared with healthy adults.

  Recruiting at 2 sites Research Center of Periodontal-Systemic Interactions · Craiova and 1 other locations · NCT07491848

• Long-term treatment with Bulevirtide for patients with Hepatitis D-related cirrhosis

  This study is testing if a medication called Bulevirtide can help people with Hepatitis D-related cirrhosis improve their health over a long period of time.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT06397859

• Effect of Bulevirtide on Chronic Hepatitis Delta in Italy

  This study is testing if the medication Bulevirtide can help people with Chronic Hepatitis Delta in Italy feel better and improve their health.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan, MI · NCT06122285

• Standardizing care for hepatitis delta in the Netherlands

  This study is trying to gather information from adults with hepatitis delta to better understand the disease and improve how it's treated.

  Recruiting Erasmus Medical Center · Rotterdam · NCT05903742

• Evaluation of patients with liver disease

  This study is trying to learn more about liver diseases by checking in on patients with conditions like hepatitis B, C, and D through regular tests and follow-ups.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00001971

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.